Genmab Completes Acquisition of ProfoundBio
GlobeNewswire
*Company Announcement*
· *Genmab has completed acquisition of ProfoundBio for USD 1.8 billion in cash*
·..
Gynecologic oncology
News and Video Search Results
News coverage
-
BioNTech to Present Clinical Data Updates for Next-Generation Immunotherapy Candidates at the ASCO Annual Meeting 2024
GlobeNewswire
-
eFFECTOR Therapeutics to Collaborate with the Dana-Farber Cancer Institute on an Investigator-Sponsored Phase 2 Clinical Trial Evaluating Zotatifin as Combination Treatment in ER+ Endometrial Cancer and in Low Grade Serous Ovarian Cancer
GlobeNewswire
-
Abstract on Phase 2 Study with IMUNON’s IMNN-001 Plus Bevacizumab Accepted for Presentation at the American Society of Clinical Oncology Annual Meeting
GlobeNewswire
-
TIVDAK® (tisotumab vedotin-tftv) Receives U.S. FDA Approval to Treat Recurrent or Metastatic Cervical Cancer
GlobeNewswire
0 shares
1 views
You might like
Gynecologic oncology media coverage
Antengene Announces One Oral and Three Poster Presentations at ASCO 2024
PR Newswire Asia
· *Oral session：*ATG-008 (mTORC1/2 Inhibitor) combined with PD-1 antibody in Phase II studies for cervical cancer
· *Three..
-
Innovent to Present Clinical Data of Multiple Novel Molecules at the 2024 ASCO Annual Meeting
PR Newswire Asia
-
Nykode Therapeutics Initiates Phase 2 Trial of VB10.16 in Second Line HPV16-Positive Cervical Cancer
GlobeNewswire
-
VS-6766 Drug Research 2024: Developed by Verastem Oncology, An RAF/MEK Clamp that Induces Inactive Complexes of MEK with ARAF, BRAF, and CRAF - Market Size, Forecast, and Emerging Insights 2019-2032
GlobeNewswire
-
Revolution Medicines Announces Publication on the Discovery of and Translational Research for RMC-6236, an Investigational RAS(ON) Multi-Selective Tri-Complex Inhibitor Designed to Block Full Spectrum of Oncogenic RAS(ON) Proteins
GlobeNewswire
Advertisement
More coverage
Genmab to Broaden and Strengthen Oncology Portfolio with Acquisition of ProfoundBio
GlobeNewswire
*Company Announcement*
· *Genmab to acquire ProfoundBio for USD 1.8 billion in cash *
· *Acquisition will give..
-
Prevent Cancer Foundation to visit Comadre a Comadre in Albuquerque
GlobeNewswire
-
Aspira Women’s Health to Present at the MedInvest Biotech & Pharma Investor Conference
GlobeNewswire
-
Theratechnologies Initiates Increased Dose Level in Phase 1 Clinical Trial of Sudocetaxel Zendusortide in Advanced Ovarian Cancer
GlobeNewswire
-
SGO 2024 | The First Published Clinical Data of Nectin-4-Targeting ADC Developed by Mabwell in Cervical Cancer Demonstrates Its Outstanding Therapeutic Potential
PR Newswire Asia